Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,212 total articles
Hydrofarm Holdings Group, Inc. announced its fourth quarter and full year 2025 financial results showing a 32.7% reduction in net sales for Q4 compared to the prior year, driven by industry oversupply and price decreases. Despite improvements in gross profit margins and reduced operating expenses due to restructuring efforts, the company reported a…
Glucotrack, Inc. announced significant progress towards filing an Investigational Device Exemption (IDE) with the U.S. FDA in Q2 2026 to initiate a U.S. clinical trial for its implantable continuous blood glucose monitoring system. Following successful first-in-human trials in Brazil and a follow-up study in Australia, the company completed key tri…
Senti Biosciences announced its fourth quarter and full year 2025 financial results, marking significant progress in its clinical pipeline, particularly with SENTI-202 for relapsed/refractory acute myeloid leukemia (AML). The company reported positive preliminary Phase 1 clinical data, received FDA Regenerative Medicine Advanced Therapy designation…
Norwegian Cruise Line Holdings Ltd. announced the appointment of John W. Chidsey as President and CEO, effective February 2026, accompanied by a new employment agreement and a $48 million restricted share unit award designed to incentivize long-term shareholder value creation over four years. The equity award includes performance-based and time-ves…
Profound Medical Corp. announced that Texas Prostate, led by Dr. James Cochran, has reached the milestone of performing 100 TULSA Procedures using Profound's TULSA-PRO system at Dallas Medical Center. The collaboration has increased procedure volume by 500% since transitioning to a Medicare payment model, accelerating adoption of this innovative, M…
Clearmind Medicine Inc., a Nasdaq-listed clinical-stage biotech company, announced the filing of a patent application in India for next-generation psychedelic compounds aimed at treating mental health disorders and addiction. This move expands the company's global intellectual property portfolio and builds on its licensing agreement with Yissum Res…
Streamex Corp. clarifies and disproves misleading third-party reports about the expiration of lock-up agreements related to its January 2026 financing. The company confirms that the previous lock-ups of certain shares held by co-founders Henry McPhie and Morgan Lekstrom were shorter than reported and that newly agreed voluntary one-year lock-ups ha…
Sportradar Group AG, a leading global sports technology company, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The report is available to investors via the company’s website and SEC filings. Sportradar provides technology and services to sports federations, media, and betting opera…
SFL Corporation Ltd., a maritime shipping company listed on the NYSE, announced its Annual General Meeting to be held on May 11, 2026, with voting record date set for April 1, 2026. The company highlighted its stable dividend record since 2004 and provided a cautionary statement about risks and uncertainties affecting its business including market …
ParaZero Technologies Ltd. announced a successful transformation in 2025 from a drone safety components supplier to a leading Tier 1 defense provider specializing in multi-layered autonomous counter-unmanned aerial systems (C-UAS). The company reported a 12% year-over-year revenue growth in 2025, with early 2026 orders already exceeding the full pr…
Aurora Mobile has entered into a strategic partnership with Soochow Securities to integrate its intelligent push notification platform, JPush, into Soochow Securities' 'Dongwu Xiucai' mobile app. This collaboration aims to improve real-time, secure delivery of financial notifications and personalized client communication, advancing Soochow's digita…
Satellos Bioscience Inc. reported significant progress in 2025, including closing a $57.2 million equity financing, commencing Nasdaq trading under ticker MSLE, and initiating two Phase 2 clinical trials (BASECAMP and TRAILHEAD) for its lead candidate SAT-3247 targeting Duchenne muscular dystrophy (DMD). Clinical data showed maintained or improved …
Legence Corp. reported record quarterly revenues of $737.6 million for Q4 2025, a 34.6% increase year-over-year, driven mainly by organic growth. The company posted a 53% increase in quarterly Adjusted EBITDA and a 49% increase in total backlog and awarded contracts to $3.7 billion. Strategic acquisitions including Bowers and Metrix enhance its mar…
Autolus Therapeutics reported fourth quarter and full year 2025 financial results highlighted by $74.3 million in net product revenue for their CAR T cell therapy AUCATZYL, approved for relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The company has launched AUCATZYL in the UK following positive NICE evaluation and expects conti…
DoubleDown Interactive Co., Ltd., a developer and publisher of digital games, announced the results of its 2026 Annual General Meeting. Shareholders approved the 18th financial statements for 2025, elected two independent directors, approved amendments to the Articles of Incorporation, and set remuneration limits for independent directors and execu…
Werewolf Therapeutics announced its Q4 and full-year 2025 financial results, highlighting a reduced net loss and operational expenses compared to 2024. The company revealed its decision to explore strategic alternatives, including potential sale, merger, or collaborations to maximize shareholder value. With $57.1 million in cash at year-end, they e…
Humacyte, Inc. announced its financial results for Q4 and full year 2025 with revenues of $0.5 million and $2.0 million respectively, driven by the commercial launch of Symvess in the US and strategic international expansion efforts. The company secured a $1.475 million purchase commitment from Saudi Arabia for clinical evaluation and is pursuing r…
Radiopharm Theranostics has dosed the first patient in its Phase 1 clinical trial of RAD 402, a monoclonal antibody radiolabeled with Terbium-161, targeting KLK3 for advanced prostate cancer. The trial aims to assess safety, tolerability, biodistribution, and preliminary efficacy, with data from initial dose levels expected by mid-2026. Preclinical…
Broad Arrow Auctions, a part of Hagerty, is presenting a rare low-mileage Ferrari Monza SP2 at the Concorso d’Eleganza Villa d’Este auction in May 2026. The Monza SP2 is a highly collectible Icona series Ferrari, noted for its performance and exclusivity, expected to attract significant international bidder interest. This event highlights Broad Arr…
Diversified Energy Company announced that its President and CFO, Bradley Gray, has transferred 15,000 shares of the company's common stock to his family members as a gift, reducing his shareholding to approximately 0.30% of the company's issued share capital. The transaction was executed outside a trading venue and involved no consideration. The co…
Pharming Group announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion recommending marketing authorization for Joenja® (leniolisib) to treat activated phosphoinositide 3-kinase delta syndrome (APDS) in patients 12 years and older. The final European Commission decision is ex…
Artelo Biosciences, a clinical-stage pharmaceutical company, has entered into definitive agreements for a private placement under Nasdaq rules to raise approximately $11 million by issuing 3.19 million common shares or pre-funded warrants along with warrants exercisable for up to 6.38 million shares. The financing proceeds will be used for working …
Toll Brothers, a leading US luxury home builder, announced the availability of two professionally designed model homes, the Aloma Coastal and Bayard Coastal, for quick move-in in their Seminole Isle community in Florida. These townhomes offer upscale living with scenic bayou views and resort-style amenities, representing the final opportunity to pu…
Zenas BioPharma announced the pricing of concurrent public offerings including $200 million aggregate principal amount of 2.50% convertible senior notes due 2032 and 5 million shares of common stock priced at $20.00 per share, aiming to raise approximately $287.5 million net proceeds. The funds will support the planned U.S. commercial launch of obe…
Moomoo, a global investment and trading platform and a subsidiary of the Nasdaq-listed FHL Holdings, is entering the second year of its partnership with the New York Mets. The collaboration aims to enhance the fan experience at Citi Field through suite experiences, interactive events, and community engagement throughout the 2026 MLB season. The par…
